14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
In a recent decision, a Pennsylvania county court ruled that the state’s Medical Marijuana Act crea...
Read More >
As the Coronavirus spreads on a worldwide level, employers have started to put into place certain me...
Read More >
After the City of Los Angeles issued a requirement that contractors develop COVID-19 plans, many cit...
Read More >
On November 6, 2019, the Supreme Court will hear oral argument for Retirement Plans Committee of IBM...
Read More >
Philadelphia’s journey toward a $15-an-hour minimum wage began last week, part of an increasingly c...
Read More >
The National Labor Relations Board (the “Board”) recently issued a decision in UPMC Presbyterian S...
Read More >